XMTR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now for an impatient investor. XMTR just broke down hard (-6.51% regular session, further -0.82% post), momentum is still bearish (MACD worsening), and insiders are aggressively selling. While fundamentals and Wall Street price targets improved after a strong 2025/Q3, the tape suggests near-term downside/volatility risk is still elevated; I’d wait for stabilization back above ~56.7–61.2 before buying.
Trend/momentum is bearish in the near term. MACD histogram is -0.578 and negatively expanding (selling pressure strengthening). RSI(6) is 26 (oversold/washed-out), which can set up a bounce, but oversold can persist when momentum is trending down. Price is sitting right at/barely below S1 support (56.734) after a sharp selloff; a clean reclaim of S1 and then the pivot (~61.226) would be the first signs the drop is digesting. Resistance levels overhead: pivot ~61.226, then R1 ~65.719. Probabilistic pattern read also leans weak near term (70% chance of ~-2.28% next day; ~-0.72% next week), with only a modest positive skew over a month (+2.28%).
Strong 2025/Q3 execution: revenue +27.54% YoY with improving profitability metrics (loss narrowing, margin up).
Analyst price targets were raised across multiple firms post-results (supports medium-term narrative of marketplace momentum).
Possible technical oversold bounce setup with RSI 26 right at a key support zone (56.7).
Clear risk-off price action: large gap-like selloff day and bearish MACD momentum.
Insiders are selling heavily (selling amount up ~1467.64% over the last month), which is a meaningful negative signal for near-term confidence.
Options open-interest skew defensive (OI put/call 1.18).
News flow provided is not business-fundamental (sponsorship extension), offering no material positive catalyst.
Prior commentary referenced “soft” 2026 revenue guidance (can cap multiple expansion and drive sell-the-news behavior).
Latest quarter: 2025/Q3. Revenue grew to ~$180.7M (+27.54% YoY). Net income improved to about -$11.6M (loss narrowed ~13.71% YoY improvement), EPS improved to -$0.23 (+9.52% YoY), and gross margin increased to ~39.86% (+1.17% YoY). Core trend: strong topline growth with incremental margin/earnings improvement—fundamentally constructive, but not currently controlling the near-term price trend.
Recent Street trend is more positive on targets but mixed on ratings. Goldman raised PT to $56 (Neutral), Cantor raised to $60 (Neutral), JPMorgan raised to $70 (Overweight), and Citizens JMP raised to $75 (Outperform). Wall Street pros: marketplace revenue acceleration, platform initiatives, enterprise exposure, and potential for sustained 20%+ growth. Cons: valuation/risk-reward viewed as more balanced by Neutral-rated firms and commentary around softer 2026 guidance; near-term sentiment is also challenged by insider selling. Politician/congress activity: no recent congress trading data available.
